Evidence map›Paper›PMID 38974027›Full record

ArticleFrontiers in microbiology2024

Screening and characterization of a novel linear B-cell epitope on orf virus F1L protein.

Zhibang Zhang, Xiaoyan Zhang, Kang Feng, Shufan Ba, Taotao Yang, Jinxiang Gong, Ziyin Yang, Hong Zhang, Zilong Sun, Pengcheng Li

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhibang Zhang *College of Life Sciences and Resource and Environment, Yichun University, Yichun, Jiangxi, China.
Xiaoyan Zhang *College of Life Sciences and Resource and Environment, Yichun University, Yichun, Jiangxi, China.
Kang Feng *College of Life Sciences and Resource and Environment, Yichun University, Yichun, Jiangxi, China.
Shufan BaCollege of Life Sciences and Resource and Environment, Yichun University, Yichun, Jiangxi, China.
Taotao YangCollege of Life Sciences and Resource and Environment, Yichun University, Yichun, Jiangxi, China.
Jinxiang GongCollege of Life Sciences and Resource and Environment, Yichun University, Yichun, Jiangxi, China.
Ziyin YangCollege of Life Sciences and Resource and Environment, Yichun University, Yichun, Jiangxi, China.
Hong ZhangXinyu Mengling Animal Husbandry Development Co., Ltd., Xinyu, Jiangxi, China.
Zilong SunShanxi Key Laboratory of Ecological Animal Science and Environmental Veterinary Medicine, College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, Shanxi, China.
Pengcheng LiCollege of Life Sciences and Resource and Environment, Yichun University, Yichun, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Orf, also known as contagious ecthyma (CE), is an acute, contagious zoonotic disease caused by the orf virus (ORFV). The F1L protein is a major immunodominant protein on the surface of ORFV and can induce the production of neutralizing antibodies. Methods: The prokaryotic expression system was used to produce the recombinant F1L protein of ORFV, which was subsequently purified and used to immunize mice. Positive hybridoma clones were screened using an indirect enzyme-linked immunosorbent assay (ELISA). The reactivity and specificity of the monoclonal antibody (mAb) were verified through Western blot and indirect immunofluorescence (IFA). The linear antigenic epitope specific to the mAb was identified through Western blot, using truncated F1L proteins expressed in eukaryotic cells. A multiple sequence alignment of the ORFV reference strains was performed to evaluate the degree of conservation of the identified epitope. Results: After three rounds of subcloning, a mAb named Ba-F1L was produced. Ba-F1L was found to react with both the exogenously expressed F1L protein and the native F1L protein from ORFV-infected cells, as confirmed by Western blot and IFA. The mAb recognized the core epitope Conclusion: The mAb produced in the present study can be used as a diagnostic reagent for detecting ORFV and as a basic tool for exploring the mechanisms of orf pathogenesis. In addition, the identified linear epitope may be valuable for the development of epitope-based vaccines.

Indexed as

F1L proteinhomology analysislinear B-cell epitopemonoclonal antibodyorf virus

Identifiers

PMID38974027
PMCPMC11224485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.